IO Biotech, Inc.·4

Dec 23, 6:53 PM ET

Sullivan Amy 4

4 · IO Biotech, Inc. · Filed Dec 23, 2024

Insider Transaction Report

Form 4
Period: 2024-12-23
Sullivan Amy
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2024-12-23$0.83/sh+10,250$8,48384,632 total
Footnotes (1)
  • [F1]The transaction was executed in multiple trades in prices ranging from $0.7861 to $0.90, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Documents

1 file
  • 4
    form4.xmlPrimary